Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
YellowBrix is a pioneer in real-time content syndication and analytics, providing intelligent information delivery solutions for corporate intranets, portals, and websites. The company specializes in using artificial intelligence and natural language processing to aggregate, categorize, and analyze news and business intelligence from thousands of global sources. In the healthcare and life sciences sector, YellowBrix is a key provider of filtered news feeds and market intelligence for organizations such as the American Diabetes Association and Blue Cross Blue Shield. Founded in 1997 and originally known as NewsReal, the company was acquired by AcquireMedia in 2011, which was subsequently acquired by Moody's Corporation in 2020.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on YellowBrix.